ERY974

· Chugai Pharmaceutical

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ERY974, covering 2024-09-05 to 2024-09-05. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Study of ERY974 in Patients With Hepatocellular Carcinoma [Phase 1]